Your browser doesn't support javascript.
loading
Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
Wilson, Sarah E; Rosella, Laura C; Wang, Jun; Le Saux, Nicole; Crowcroft, Natasha S; Harris, Tara; Bolotin, Shelly; Deeks, Shelley L.
Afiliação
  • Wilson SE; Public Health Ontario, Toronto, Ontario, Canada.
  • Rosella LC; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Wang J; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Le Saux N; Public Health Ontario, Toronto, Ontario, Canada.
  • Crowcroft NS; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Harris T; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Bolotin S; Public Health Ontario, Toronto, Ontario, Canada.
  • Deeks SL; Division of Infectious Disease, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
PLoS One ; 11(5): e0154340, 2016.
Article em En | MEDLINE | ID: mdl-27168335
ABSTRACT

OBJECTIVE:

To evaluate the direct and indirect population impact of rotavirus (RV) immunization on hospitalizations and emergency department (ED) visits for acute gastroenteritis (AGE) in Ontario before and after the publicly-funded RV immunization program.

METHODS:

Administrative data was used to identify ED visits and hospitalizations for all Ontarians using ICD-10 codes. We used two outcome definitions RV-specific AGE (RV-AGE) and codes representing RV-, other viral and cause unspecified AGE ("overall AGE"). The pre-program and public program periods were August 1, 2005 to July 31, 2011; and August 1, 2011 to March 31, 2013, respectively. A negative binominal regression model that included the effect of time was used to calculate rates and rate ratios (RRs) and 95% confidence intervals (CIs) for RV-AGE and overall AGE between periods, after adjusting for age, seasonality and secular trends. Analyses were conducted for all ages combined and age stratified.

RESULTS:

Relative to the pre-program period, the adjusted RRs for RV-AGE and overall AGE hospitalizations in the public program period were 0.29 (95%CI 0.22-0.39) and 0.68 (95%CI 0.62-0.75), respectively. Significant reductions in RV-AGE hospitalizations were noted overall and for the following age bands < 12 months, 12-23 months, 24-35 months, 3-4 years, and 5-19 years. Significant declines in overall AGE hospitalizations were observed across all age bands, including older adults > = 65 years (RR 0.80, 95%CI 0.72-0.90). The program was associated with adjusted RRs of 0.32 (95% CI 0.20-0.52) for RV-AGE ED visits and 0.90 (95% CI 0.85-0.96) for overall AGE ED visits.

CONCLUSIONS:

This large, population-based study provides evidence of the impact of RV vaccine in preventing hospitalizations and ED visits for RV-AGE and overall AGE, including herd effects.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Vacinação em Massa / Programas de Imunização / Vacinas contra Rotavirus / Serviço Hospitalar de Emergência / Gastroenterite / Hospitalização Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Vacinação em Massa / Programas de Imunização / Vacinas contra Rotavirus / Serviço Hospitalar de Emergência / Gastroenterite / Hospitalização Idioma: En Ano de publicação: 2016 Tipo de documento: Article